Towards personalized antithrombotic management with drugs and devices across the cardiovascular spectrum

医学 血栓 心房颤动 冲程(发动机) 阿司匹林 卵圆孔未闭 心肌梗塞 内科学 华法林 心脏病学 机械工程 工程类 偏头痛
作者
Thomas F. Lüscher,Allan Davies,Jürg H. Beer,Marco Valgimigli,Christoph Nienaber,A. John Camm,Iris Baumgärtner,Hans‐Christoph Diener,Stavros Konstantinides
出处
期刊:European Heart Journal [Oxford University Press]
卷期号:43 (10): 940-958 被引量:12
标识
DOI:10.1093/eurheartj/ehab642
摘要

Abstract Intravascular thrombus formation and embolization are among the most frequent events leading to a number of cardiovascular conditions with high morbidity and mortality. The underlying causes are stasis of the circulating blood, genetic and acquired coagulation disorders, and reduced antithrombotic or prothrombotic properties of the vascular wall (Virchow’s triad). In the venous system, intravascular thrombi can cause venous thrombosis and pulmonary and even peripheral embolism including ischaemic stroke [through a patent foramen ovale (PFO)]. Thrombi in the left atrium and its appendage or ventricle form in the context of atrial fibrillation and infarction, respectively. Furthermore, thrombi can form on native or prosthetic aortic valves, within the aorta (in particular at sites of ulcers, aortic dissection, and abdominal aneurysms), and in cerebral and peripheral arteries causing stroke and critical limb ischaemia, respectively. Finally, thrombotic occlusion may occur in arteries supplying vital organs such the heart, brain, kidney, and extremities. Thrombus formation and embolization can be managed with anticoagulants and devices depending on where they form and embolize and on patient characteristics. Vitamin K antagonists are preferred in patients with mechanical valves, while novel oral anticoagulants are first choice in most other cardiovascular conditions, in particular venous thromboembolism and atrial fibrillation. As anticoagulants are associated with a risk of bleeding, devices such as occluders of a PFO or the left atrial appendage are preferred in patients with an increased bleeding risk. Platelet inhibitors such as aspirin and/or P2Y12 antagonists are preferred in the secondary prevention of coronary artery disease, stroke, and peripheral artery disease either alone or in combination depending on the clinical condition. A differential and personalized use of anticoagulants, platelet inhibitors, and devices is recommended and reviewed in this article.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
开放诗完成签到 ,获得积分10
刚刚
岑从寒发布了新的文献求助10
5秒前
孙香完成签到,获得积分10
7秒前
szj关闭了szj文献求助
7秒前
7秒前
揽月yue完成签到,获得积分10
9秒前
科研通AI6.4应助李1669966采纳,获得10
9秒前
科研通AI6.4应助坚强山雁采纳,获得10
10秒前
10秒前
10秒前
11秒前
yangbo666完成签到,获得积分10
12秒前
dracovu发布了新的文献求助10
15秒前
赘婿应助你薛的对啊采纳,获得10
15秒前
蓝天发布了新的文献求助10
15秒前
仲乔妹完成签到,获得积分10
15秒前
852应助chino采纳,获得10
16秒前
Dou发布了新的文献求助10
16秒前
wybe完成签到,获得积分10
16秒前
17秒前
朱美润发布了新的文献求助10
18秒前
健忘的夜阑完成签到,获得积分10
18秒前
18秒前
彩虹壹号2704完成签到,获得积分10
19秒前
Glimmer完成签到,获得积分10
19秒前
21秒前
23秒前
25秒前
26秒前
26秒前
瘦瘦冬寒发布了新的文献求助10
27秒前
27秒前
FashionBoy应助黎湘笙采纳,获得10
27秒前
29秒前
岑从寒完成签到,获得积分10
29秒前
豆豆完成签到 ,获得积分10
29秒前
海石酸辣完成签到 ,获得积分10
29秒前
彭泽阳发布了新的文献求助10
30秒前
羊羊羊冲发布了新的文献求助10
31秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Principles of town planning: translating concepts to applications 1000
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
核安全综合知识2024版 500
Photothermal Science and Techniques 500
Digital Displacement Hydrostatic Transmission for Rotorcraft and Distributed Propulsion 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7705426
求助须知:如何正确求助?哪些是违规求助? 9262995
关于积分的说明 20041027
捐赠科研通 7280933
什么是DOI,文献DOI怎么找? 3295246
关于科研通互助平台的介绍 2450264
邀请新用户注册赠送积分活动 2302113